HORSHAM, England--(BUSINESS WIRE)--Cmed Clinical Services, the global CRO specialised in the design and delivery of traditional and innovative pre-phase III clinical trials, announces the creation of its new Medical and Regulatory Affairs Group. Experienced professionals from across the industry have been brought together to create this team, in order to supplement the company’s mission to become recognized as the early pre-phase III clinical trial specialists.
